Study seeks best speech therapy for children with cochlear implants
NCT ID NCT07447427
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study observes 60 children with severe hearing loss who received cochlear implants before age 2. Researchers will track their speech therapy sessions and language skills over time to see which therapy approaches and how much therapy lead to better language development. The goal is to improve care, not to test a new drug or device.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify which speech therapy methods work best for children with cochlear implants, improving future care guidelines.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children followed at Necker Hospital for their hearing loss and cochlear implantation
- Ages
-
32 to 48 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children with severe to profound prelingual hearing loss * Implanted between 8 and 24 months of age * At least 24 months of follow-up after implantation * No parental objection from legal guardians Exclusion Criteria: * Children with progressive hearing loss * Severe neurological pathology, identified by MRI and/or neuro-pediatric assessment * Suspected or diagnosed Autism Spectrum Disorder (ASD)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Severe to profound prelingual hearing loss are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hôpital Necker - Enfants Malades - Service d'ORL et chirurgie cervico-faciale
RECRUITINGParis, Île-de-France Region, 75015, France